Tesseract Medical Research

Tesseract Medical Research has 28 on-market SKUs in the DSLD, first entered 2022-01-22. 64.3% of its products declare at least one proprietary blend, and 30.0% of all its all-time SKUs are now off-market.

Report card

• Median dose adequacy (elemental dose ÷ studied low dose, pooled across compounds): 3
• % with a third-party certification statement (USP/NSF/Informed Sport/GMP, as asserted on label): 0.0%
• Average excipient count per product: 5.1
• First entry: 2022-01-22 · Latest entry: 2025-07-24
• Mineral/vitamin rows by quality tier: tier 1: 50%, tier 2: 50%

Products (40)